JANE STREET GROUP, LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 197 filers reported holding BLUEBIRD BIO INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$1,845,529
-41.2%
607,082
-36.3%
0.00%0.0%
Q2 2023$3,136,341
+91.9%
953,295
+85.4%
0.00%0.0%
Q1 2023$1,634,762
-31.3%
514,076
+49.4%
0.00%0.0%
Q4 2022$2,380,480
-41.0%
344,000
-46.1%
0.00%
-50.0%
Q3 2022$4,038,000
+232.3%
637,796
+117.4%
0.00%
+100.0%
Q2 2022$1,215,000
+174.9%
293,423
+221.3%
0.00%
Q1 2022$442,000
-82.5%
91,319
-63.7%
0.00%
-100.0%
Q4 2021$2,532,000
-65.6%
251,324
-34.7%
0.00%
-50.0%
Q3 2021$7,356,000
-36.2%
384,930
+6.8%
0.00%
-50.0%
Q2 2021$11,531,000
-25.1%
360,561
-29.4%
0.00%
-50.0%
Q1 2021$15,393,000
+6.9%
510,572
+53.5%
0.01%
+14.3%
Q4 2020$14,394,000
-7.7%
332,675
+15.1%
0.01%
-30.0%
Q3 2020$15,598,000
+19.2%
289,114
+34.8%
0.01%0.0%
Q2 2020$13,088,000
+543.1%
214,407
+384.3%
0.01%
+400.0%
Q1 2020$2,035,000
-89.3%
44,269
-79.6%
0.00%
-92.6%
Q4 2019$19,064,000
+157.6%
217,262
+169.5%
0.03%
+125.0%
Q3 2019$7,402,000
-14.8%
80,616
+18.0%
0.01%
-20.0%
Q2 2019$8,686,000
-28.7%
68,291
-11.8%
0.02%
-25.0%
Q1 2019$12,184,000
+136.6%
77,438
+49.1%
0.02%
+81.8%
Q4 2018$5,150,000
-8.1%
51,921
+35.3%
0.01%0.0%
Q3 2018$5,602,000
-63.0%
38,372
-60.2%
0.01%
-69.4%
Q2 2018$15,143,000
+117.7%
96,483
+136.8%
0.04%
+89.5%
Q1 2018$6,956,000
-41.2%
40,738
-38.7%
0.02%
-44.1%
Q4 2017$11,838,000
-33.0%
66,468
-48.3%
0.03%
-40.4%
Q3 2017$17,664,000
+161.5%
128,603
+99.9%
0.06%
+147.8%
Q2 2017$6,756,000
+1153.4%
64,321
+984.5%
0.02%
+1050.0%
Q1 2017$539,000
-83.9%
5,931
-89.1%
0.00%
-85.7%
Q4 2016$3,344,000
+28.0%
54,210
+40.6%
0.01%
+7.7%
Q3 2016$2,613,000
+194.3%
38,555
+87.9%
0.01%
+225.0%
Q2 2016$888,000
-44.2%
20,519
-45.2%
0.00%
-55.6%
Q1 2016$1,591,000
-54.9%
37,425
-31.9%
0.01%
-59.1%
Q4 2015$3,529,000
+115.6%
54,951
+187.0%
0.02%
+120.0%
Q3 2015$1,637,000
-58.4%
19,148
-18.0%
0.01%
-60.0%
Q2 2015$3,932,000
+448.4%
23,350
+293.5%
0.02%
+316.7%
Q1 2015$717,000
+1.4%
5,934
-69.9%
0.01%
-14.3%
Q3 2014$707,000
-32.7%
19,709
-27.6%
0.01%
-46.2%
Q2 2014$1,050,00027,2320.01%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders